Insider Trading activities at Vanda Pharmaceuticals Inc. (VNDA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vanda Pharmaceuticals Inc. (VNDA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vanda Pharmaceuticals Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1347178.

Total stock buying since 2015: $10,826,033.
Total stock sales since 2015: $59,330,196.
Total stock option exercises since 2015: $10,184,107.


15 insiders reported insider trading activities at Vanda Pharmaceuticals Inc. (VNDA):
Insider trading activities of Chrousos Phaedra
Insider trading activities of Polymeropoulos Mihael Hristos
Insider trading activities of Gulino Richard L.
Insider trading activities of Reverberi Gian Piero
Insider trading activities of Kelly James Patrick
Insider trading activities of Williams Timothy
Insider trading activities of Mitchell Stephen Ray
Insider trading activities of Birznieks Gunther
Insider trading activities of Jones Aranthan Ii
Insider trading activities of Moran Kevin Patrick
Insider trading activities of Dugan Richard W
Insider trading activities of Baroldi Paolo
Insider trading activities of Deerfield Special Situations Fund, L.p.
Insider trading activities of Wijkstrom Joakim
Insider trading activities of Watkins Thomas

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Vanda Pharmaceuticals Inc. (VNDA).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 82,000 $387,616 7,000 $32,130 0 $0
2024 0 $0 123,349 $526,683 0 $0
2023 0 $0 147,282 $922,720 0 $0
2022 0 $0 123,098 $1,330,941 60,000 $249,000
2021 0 $0 445,929 $7,848,942 230,243 $1,522,813
2020 0 $0 243,657 $3,006,086 180,000 $1,533,899
2019 0 $0 477,790 $8,181,396 440,000 $5,222,948
2018 0 $0 301,533 $4,890,760 381,250 $572,400
2017 0 $0 61,425 $952,126 139,844 $0
2016 0 $0 1,711,644 $27,529,380 83,282 $0
2015 1,212,534 $10,438,417 366,228 $4,109,032 730,503 $1,083,047

Table 2. Monthly summary of insider trading at Vanda Pharmaceuticals Inc. (VNDA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-06 0 $0 7,000 $32,130 0 $0
2025-05 10,000 $43,949 0 $0 0 $0
2025-03 30,000 $147,399 0 $0 0 $0
2025-02 42,000 $196,268 0 $0 0 $0
2024-07 0 $0 2,251 $13,325 0 $0
2024-03 0 $0 121,098 $513,358 0 $0
2023-08 0 $0 10,224 $61,099 0 $0
2023-07 0 $0 2,212 $13,942 0 $0
2023-06 0 $0 30,600 $196,465 0 $0
2023-03 0 $0 104,246 $651,214 0 $0
2022-08 0 $0 8,300 $85,606 0 $0
2022-07 0 $0 2,239 $24,561 0 $0
2022-06 0 $0 22,023 $216,927 45,000 $186,750
2022-05 0 $0 6,500 $64,050 15,000 $62,250
2022-03 0 $0 84,036 $939,797 0 $0
2021-12 0 $0 46,200 $739,338 71,676 $349,778
2021-11 0 $0 50,000 $824,300 78,324 $382,221
2021-09 0 $0 35,933 $597,374 31,228 $365,276
2021-08 0 $0 7,365 $116,177 0 $0
2021-07 0 $0 9,380 $183,746 0 $0
2021-06 0 $0 7,075 $137,252 4,015 $42,438
2021-03 0 $0 278,404 $5,036,240 15,000 $169,800
2021-02 0 $0 11,572 $214,515 30,000 $213,300
2020-12 0 $0 125,252 $1,633,494 150,000 $1,312,499

Table 3. Detailed insider trading at Vanda Pharmaceuticals Inc. (VNDA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-06-13 Mitchell Stephen Ray Sale 7,000 4.59 32,130
2025-05-21 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 4.39 43,949
2025-03-06 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 5.01 50,150
2025-03-05 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 5.02 50,199
2025-03-03 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 4.71 47,050
2025-02-28 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 4.76 47,600
2025-02-27 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 4.76 47,600
2025-02-26 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 4.76 47,650
2025-02-25 Polymeropoulos Mihael Hristos (President and CEO) Buy 10,000 4.46 44,640
2025-02-21 Moran Kevin Patrick (SVP, CFO & Treasurer) Buy 2,000 4.39 8,778
2024-07-29 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 2,251 5.92 13,325
2024-03-05 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 8,902 4.20 37,415
2024-03-05 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 9,229 4.21 38,826
2024-03-05 Williams Timothy (SVP & General Counsel) Sale 8,941 4.18 37,400
2024-03-05 Birznieks Gunther (SVP, Business Development) Sale 8,684 4.13 35,882
2024-03-05 Polymeropoulos Mihael Hristos (President and CEO) Sale 24,288 4.13 100,285
2024-03-04 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 5,798 4.48 25,980
2024-03-04 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 7,498 4.41 33,088
2024-03-04 Williams Timothy (SVP & General Counsel) Sale 8,147 4.41 35,920
2024-03-04 Birznieks Gunther (SVP, Business Development) Sale 8,727 4.30 37,491
2024-03-04 Polymeropoulos Mihael Hristos (President and CEO) Sale 30,884 4.24 131,071
2023-08-21 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 3,724 5.84 21,748
2023-08-10 Mitchell Stephen Ray (Director) Sale 6,500 6.05 39,351
2023-07-28 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 2,212 6.30 13,942
2023-06-15 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 16,000 6.29 100,704
2023-06-13 Williams Timothy (SVP & General Counsel) Sale 14,600 6.56 95,761
2023-03-03 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 5,968 6.28 37,496
2023-03-03 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 4,113 6.32 25,994
2023-03-03 Williams Timothy (SVP & General Counsel) Sale 8,301 6.25 51,889
2023-03-03 Birznieks Gunther (SVP, Business Development) Sale 8,268 6.26 51,790
2023-03-03 Polymeropoulos Mihael Hristos (President and CEO) Sale 22,538 6.25 140,885
2023-03-02 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 7,966 6.26 49,843
2023-03-02 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 7,720 6.23 48,126
2023-03-02 Williams Timothy (SVP & General Counsel) Sale 8,437 6.25 52,689
2023-03-02 Birznieks Gunther (SVP, Business Development) Sale 8,509 6.20 52,789
2023-03-02 Polymeropoulos Mihael Hristos (President and CEO) Sale 22,426 6.23 139,713
2022-08-15 Williams Timothy (SVP & General Counsel) Sale 8,300 10.31 85,606
2022-07-28 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 2,239 10.97 24,561
2022-06-13 Mitchell Stephen Ray (Director) Sale 2,700 9.48 25,593
2022-06-02 Watkins Thomas (Director) Sale 12,882 9.90 127,556
2022-06-02 Watkins Thomas (Director) Option Ex 30,000 4.15 124,500
2022-05-31 Dugan Richard W (Director) Sale 6,500 9.85 64,050
2022-05-31 Dugan Richard W (Director) Option Ex 15,000 4.15 62,250
2022-03-02 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 8,832 11.28 99,651
2022-03-02 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 6,974 11.19 78,059
2022-03-02 Williams Timothy (SVP & General Counsel) Sale 12,060 11.09 133,781
2022-03-02 Birznieks Gunther (SVP, Business Development) Sale 11,517 11.27 129,796
2022-03-02 Polymeropoulos Mihael Hristos (President and CEO) Sale 29,588 11.15 329,935
2022-03-01 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 3,473 11.19 38,862
2022-03-01 Birznieks Gunther (SVP, Business Development) Sale 4,084 11.19 45,699
2022-03-01 Polymeropoulos Mihael Hristos (President and CEO) Sale 7,508 11.19 84,014
2021-12-01 Polymeropoulos Mihael Hristos (President and CEO) Sale 46,200 16.00 739,338
2021-12-01 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 71,676 4.88 349,778
2021-11-30 Polymeropoulos Mihael Hristos (President and CEO) Sale 50,000 16.49 824,300
2021-11-30 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 78,324 4.88 382,221
2021-09-15 Jones Aranthan Ii (Chief Corp. Affairs Officer) Sale 16,824 16.49 277,394
2021-09-15 Jones Aranthan Ii (Chief Corp. Affairs Officer) Option Ex 12,119 11.79 142,943
2021-09-09 Mitchell Stephen Ray (Director) Sale 19,109 16.75 319,980
2021-09-09 Mitchell Stephen Ray (Director) Option Ex 19,109 11.63 222,333
2021-08-20 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 3,650 15.39 56,188
2021-08-16 Williams Timothy (SVP & General Counsel) Sale 3,715 16.15 59,989
2021-07-28 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 2,130 19.24 40,972
2021-07-26 Jones Aranthan Ii (Chief Corp. Affairs Officer) Sale 7,250 19.69 142,774
2021-06-15 Mitchell Stephen Ray (Director) Sale 5,000 19.42 97,120
2021-06-15 Mitchell Stephen Ray (Director) Option Ex 4,015 10.57 42,438
2021-06-14 Chrousos Phaedra (Director) Sale 2,075 19.34 40,132
2021-03-15 Jones Aranthan Ii (Chief Corp. Affairs Officer) Sale 18,000 17.72 319,014
2021-03-15 Jones Aranthan Ii (Chief Corp. Affairs Officer) Option Ex 15,000 11.32 169,800
2021-03-08 Polymeropoulos Mihael Hristos (President and CEO) Sale 175,000 18.00 3,150,000
2021-03-05 Williams Timothy (SVP & General Counsel) Sale 5,600 17.86 100,043
2021-03-02 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 6,044 18.23 110,188
2021-03-02 Jones Aranthan Ii (Chief Corp. Affairs Officer) Sale 3,865 18.04 69,716
2021-03-02 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 3,888 18.45 71,729
2021-03-02 Williams Timothy (SVP & General Counsel) Sale 7,674 18.54 142,306
2021-03-02 Birznieks Gunther (SVP, Business Development) Sale 16,620 18.19 302,267
2021-03-02 Polymeropoulos Mihael Hristos (President and CEO) Sale 15,206 18.34 278,908
2021-03-01 Moran Kevin Patrick (SVP, CFO & Treasurer) Sale 3,327 18.57 61,779
2021-03-01 Williams Timothy (SVP & General Counsel) Sale 11,856 18.60 220,545
2021-03-01 Birznieks Gunther (SVP, Business Development) Sale 3,845 18.66 71,743
2021-03-01 Polymeropoulos Mihael Hristos (President and CEO) Sale 7,479 18.45 138,002
2021-02-16 Watkins Thomas (Director) Sale 5,818 18.54 107,854
2021-02-16 Watkins Thomas (Director) Option Ex 15,000 7.11 106,650
2021-02-16 Dugan Richard W (Director) Sale 5,754 18.54 106,661
2021-02-16 Dugan Richard W (Director) Option Ex 15,000 7.11 106,650
2020-12-15 Polymeropoulos Mihael Hristos (President and CEO) Sale 39,150 13.00 508,832
2020-12-15 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 46,663 8.75 408,301
2020-12-14 Polymeropoulos Mihael Hristos (President and CEO) Sale 51,049 13.19 673,285
2020-12-14 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 61,520 8.75 538,300
2020-12-11 Polymeropoulos Mihael Hristos (President and CEO) Sale 35,053 12.88 451,377
2020-12-11 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 41,817 8.75 365,898
2020-08-20 Wijkstrom Joakim (SVP, Chief Marketing Officer) Sale 3,710 11.08 41,110
2020-08-14 Williams Timothy (SVP & General Counsel) Sale 3,684 11.81 43,526
2020-08-12 Jones Aranthan Ii (Chief Corp. Affairs Officer) Sale 7,200 11.81 85,017
2020-07-27 Jones Aranthan Ii (Chief Corp. Affairs Officer) Sale 7,313 10.62 77,634
2020-05-29 Watkins Thomas (Director) Sale 9,677 11.50 111,285
2020-05-29 Watkins Thomas (Director) Option Ex 15,000 7.38 110,700
2020-05-28 Dugan Richard W (Director) Sale 10,129 11.04 111,803
2020-05-28 Dugan Richard W (Director) Option Ex 15,000 7.38 110,700
2020-03-03 Williams Timothy (SVP & General Counsel) Sale 1,237 10.51 13,003
2020-03-03 Birznieks Gunther (SVP, Business Development) Sale 5,535 10.66 58,986
2020-03-03 Kelly James Patrick (EVP & Chief Financial Officer) Sale 5,889 10.76 63,359
2020-03-03 Polymeropoulos Mihael Hristos (President and CEO) Sale 5,152 10.97 56,543
2020-03-02 Williams Timothy (SVP & General Counsel) Sale 3,148 10.30 32,436
2020-03-02 Birznieks Gunther (SVP, Business Development) Sale 12,223 10.04 122,682
2020-03-02 Reverberi Gian Piero (SVP & Chief Commercial Officer) Sale 1,450 10.18 14,755
2020-03-02 Kelly James Patrick (EVP & Chief Financial Officer) Sale 12,968 10.19 132,092
2020-03-02 Polymeropoulos Mihael Hristos (President and CEO) Sale 10,428 10.57 110,213
2020-01-02 Birznieks Gunther (SVP, Business Development) Sale 4,020 15.93 64,022
2020-01-02 Reverberi Gian Piero (SVP & Chief Commercial Officer) Sale 1,155 16.06 18,550
2020-01-02 Kelly James Patrick (EVP & Chief Financial Officer) Sale 4,020 15.94 64,086
2020-01-02 Polymeropoulos Mihael Hristos (President and CEO) Sale 9,467 16.00 151,490
2019-12-12 Polymeropoulos Mihael Hristos (President and CEO) Sale 70,036 16.98 1,189,351
2019-12-12 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 85,801 10.65 913,780
2019-12-11 Polymeropoulos Mihael Hristos (President and CEO) Sale 72,373 16.92 1,224,406
2019-12-11 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 89,199 10.65 949,969
2019-08-26 Dugan Richard W (Director) Sale 15,000 14.85 222,750
2019-08-26 Dugan Richard W (Director) Option Ex 15,000 14.78 221,700
2019-08-14 Williams Timothy (SVP & General Counsel) Sale 2,575 14.69 37,829
2019-05-21 Polymeropoulos Mihael Hristos (President and CEO) Sale 72,872 15.34 1,117,929
2019-05-21 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 79,019 12.55 991,688
2019-05-20 Polymeropoulos Mihael Hristos (President and CEO) Sale 67,418 15.12 1,019,090
2019-05-20 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 73,608 12.55 923,780
2019-05-17 Polymeropoulos Mihael Hristos (President and CEO) Sale 77,225 15.56 1,201,698
2019-05-17 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 97,373 12.55 1,222,031
2019-03-04 Birznieks Gunther (SVP, Business Development) Sale 8,788 19.89 174,766
2019-03-04 Reverberi Gian Piero (SVP & Chief Commercial Officer) Sale 443 19.92 8,822
2019-03-04 Kelly James Patrick (EVP & Chief Financial Officer) Sale 8,751 19.88 173,961
2019-03-04 Polymeropoulos Mihael Hristos (President and CEO) Sale 38,166 19.41 740,802
2019-03-01 Birznieks Gunther (SVP, Business Development) Sale 3,741 20.14 75,325
2019-03-01 Reverberi Gian Piero (SVP & Chief Commercial Officer) Sale 438 20.16 8,832
2019-03-01 Kelly James Patrick (EVP & Chief Financial Officer) Sale 4,976 20.15 100,271
2019-03-01 Polymeropoulos Mihael Hristos (President and CEO) Sale 6,500 20.22 131,423
2019-01-03 Birznieks Gunther (SVP, Business Development) Sale 1,619 26.09 42,231
2019-01-03 Kelly James Patrick (EVP & Chief Financial Officer) Sale 1,619 26.09 42,231
2019-01-03 Polymeropoulos Mihael Hristos (President and CEO) Sale 4,447 26.04 115,804
2019-01-02 Birznieks Gunther (SVP, Business Development) Sale 4,442 26.62 118,259
2019-01-02 Reverberi Gian Piero (SVP & Chief Commercial Officer) Sale 1,130 26.61 30,064
2019-01-02 Kelly James Patrick (EVP & Chief Financial Officer) Sale 4,442 26.62 118,263
2019-01-02 Polymeropoulos Mihael Hristos (President and CEO) Sale 10,789 26.63 287,289
2018-05-03 Watkins Thomas (Director) Option Ex 15,000 4.98 74,700
2018-03-19 Dugan Richard W (Director) Option Ex 15,000 4.98 74,700
2018-03-01 Birznieks Gunther (SVP, Business Development) Sale 8,525 18.72 159,605
2018-03-01 Gulino Richard L. (SVP, General Counsel & Sec.) Sale 3,660 18.71 68,474
2018-03-01 Kelly James Patrick (EVP & Chief Financial Officer) Sale 8,532 18.72 159,710
2018-03-01 Polymeropoulos Mihael Hristos (President and CEO) Sale 60,966 18.71 1,140,978
2018-01-02 Birznieks Gunther (SVP, Business Development) Sale 8,568 15.26 130,773
2018-01-02 Gulino Richard L. (SVP, General Counsel & Sec.) Sale 10,367 15.20 157,568
2018-01-02 Gulino Richard L. (SVP, General Counsel & Sec.) Option Ex 20,000 .00 0
2018-01-02 Reverberi Gian Piero (SVP & Chief Commercial Officer) Option Ex 20,000 .00 0
2018-01-02 Kelly James Patrick (EVP & Chief Financial Officer) Sale 9,155 15.35 140,492
2018-01-02 Kelly James Patrick (EVP & Chief Financial Officer) Option Ex 17,500 .00 0
2018-01-02 Polymeropoulos Mihael Hristos (President and CEO) Sale 191,760 15.30 2,933,160
2018-01-02 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 293,750 1.44 423,000
2017-01-03 Gulino Richard L. (SVP, General Counsel & Sec.) Sale 10,900 15.51 169,091
2017-01-03 Gulino Richard L. (SVP, General Counsel & Sec.) Option Ex 20,000 .00 0
2017-01-03 Reverberi Gian Piero (SVP & Chief Commercial Officer) Option Ex 20,000 .00 0
2017-01-03 Kelly James Patrick (SVP, CFO & Treasurer) Sale 10,895 15.51 169,014
2017-01-03 Kelly James Patrick (SVP, CFO & Treasurer) Option Ex 19,844 .00 0
2017-01-03 Baroldi Paolo (SVP & Chief Medical Officer) Sale 16,300 15.51 252,780
2017-01-03 Baroldi Paolo (SVP & Chief Medical Officer) Option Ex 30,000 .00 0
2017-01-03 Polymeropoulos Mihael Hristos (President and CEO) Sale 23,330 15.48 361,241
2017-01-03 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 50,000 .00 0
2016-09-23 Deerfield Special Situations Fund, L.p. Sale 779,497 16.71 13,023,056
2016-09-22 Deerfield Special Situations Fund, L.p. Sale 340,964 16.24 5,536,914
2016-09-19 Deerfield Special Situations Fund, L.p. Sale 45,811 15.54 712,131
2016-09-16 Deerfield Special Situations Fund, L.p. Sale 300,372 15.62 4,691,510
2016-09-15 Deerfield Special Situations Fund, L.p. Sale 201,703 15.76 3,177,830
2016-01-04 Kelly James Patrick (SVP, CFO, Sec & Treasurer) Sale 9,564 8.96 85,693
2016-01-04 Kelly James Patrick (SVP, CFO, Sec & Treasurer) Option Ex 17,032 .00 0
2016-01-04 Baroldi Paolo (SVP & Chief Medical Officer) Sale 12,380 8.96 110,924
2016-01-04 Baroldi Paolo (SVP & Chief Medical Officer) Option Ex 22,500 .00 0
2016-01-04 Polymeropoulos Mihael Hristos (President and CEO) Sale 21,353 8.96 191,322
2016-01-04 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 43,750 .00 0
2015-12-16 Deerfield Special Situations Fund, L.p. Buy 11,170 8.97 100,161
2015-12-11 Deerfield Special Situations Fund, L.p. Buy 322,872 8.61 2,779,605
2015-12-10 Deerfield Special Situations Fund, L.p. Buy 103,110 8.59 885,714
2015-12-09 Deerfield Special Situations Fund, L.p. Buy 775,382 8.61 6,672,937
2015-09-10 Polymeropoulos Mihael Hristos (President and CEO) Sale 102,162 12.73 1,300,522
2015-09-10 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 147,626 4.73 698,270
2015-09-09 Polymeropoulos Mihael Hristos (President and CEO) Sale 29,577 12.51 369,978
2015-09-09 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 42,747 4.73 202,193
2015-05-22 Polymeropoulos Mihael Hristos (President and CEO) Sale 169,238 10.36 1,753,982
2015-05-22 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 359,815 .33 119,098
2015-05-21 Polymeropoulos Mihael Hristos (President and CEO) Sale 17,157 10.33 177,283
2015-05-21 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 35,806 .33 11,851
2015-03-10 Kelly James Patrick (SVP, CFO, Sec & Treasurer) Sale 12,450 10.53 131,098
2015-03-10 Kelly James Patrick (SVP, CFO, Sec & Treasurer) Option Ex 24,531 .00 0
2015-03-10 Baroldi Paolo (SVP & Chief Medical Officer) Sale 8,940 10.54 94,227
2015-03-10 Baroldi Paolo (SVP & Chief Medical Officer) Option Ex 17,500 .00 0
2015-03-10 Polymeropoulos Mihael Hristos (President and CEO) Sale 21,900 10.53 230,607
2015-03-10 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 43,750 .00 0
2015-03-09 Dugan Richard W (Director) Sale 4,804 10.69 51,335
2015-03-09 Dugan Richard W (Director) Option Ex 10,574 4.73 50,046
2015-02-05 Polymeropoulos Mihael Hristos (President and CEO) Option Ex 48,154 .03 1,589

Insider trading activities including stock purchases, stock sales, and option exercises of VNDA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vanda Pharmaceuticals Inc. (symbol VNDA, CIK number 1347178) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.